Effect of glycosaminoglycans on thrombin-induced clotting of normal and antithrombin III-deficient plasmas.
D000328:Adult; D000818:Animals; D000925:Anticoagulants; D000990:Antithrombin III / Q000008:administration & dosage / Q000235:genetics*; D001777:Blood Coagulation / Q000187:drug effects*; D002417:Cattle; D002809:Chondroitin Sulfates / Q000494:pharmacology; D003871:Dermatan Sulfate / Q000494:pharmacology; D006025:Glycosaminoglycans / Q000494:pharmacology*; D006497:Heparan Sulfate / Q000494:pharmacology; D006801:Humans; D008297:Male; D013917:Thrombin / Q000494:pharmacology*; D013918:Thrombin Time
D000925:Anticoagulants; D000990:Antithrombin III; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D013917:Thrombin